Product Pathways - Neuroscience
Phospho-mu-Opioid Receptor (Ser375) Antibody #3451
| Applications | Reactivity | Sensitivity | MW (kDa) | Source |
|---|---|---|---|---|
| W IP IF-F IF-IC | M (H) | Transfected Only | 70 to 90 | Rabbit |
Applications Key:
W=Western Blotting
IP=Immunoprecipitation
IF-F=Immunofluorescence (Frozen)
IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:
H=Human
M=Mouse
Species cross-reactivity is determined by Western blot.
Specificity / Sensitivity
Phospho-µ-Opioid Receptor (Ser375) Antibody detects transfected µ-opioid receptor only when phosphorylated at Ser375 of mouse MOR (or Ser377 of human MOR).
Source / Purification
Polyclonal antibodies are produced by immunizing rabbits with a synthetic phospho-peptide (KLH-coupled) corresponding to residues surrounding Ser377 of human (homologous to Ser375 of mouse) µ-opioid receptor. Antibodies are purified by protein A and peptide affinity chromatography.
Western Blotting
Western blot analysis of extracts from CHO cells, stably transfected with µ-opioid receptor, untreated or DAMGO-treated (1 mM) for various times, using Phospho-µ-Opioid Receptor (Ser375) Antibody.
Western Blotting
Western blot analysis of extracts from CHO cells, stably transfected with S375A mutant or Wild-type (WT) µ-opioid receptor, untreated or DAMGO-treated (1 mM for 5 minutes), using Phospho-µ-Opioid Receptor (Ser375) Antibody.
IF-IC
Immunofluorescent staining CHO cells, stably transfected with µ-opioid receptor, untreated (A, C) or morphine-treated (1 µM) (B, D), using Phospho-µ-Opioid Receptor (Ser375) Antibody (A, B) or control µ-opioid receptor antibody (C, D).
Background
The μ-opioid receptor (MOR) belongs to the superfamily of G-protein-coupled receptors. MOR mediates the analgesic and rewarding effects of morphine and other opiates as well as the actions of several endogenous opioid peptides (1). Upon binding to its ligands, this Gi-coupled receptor inactivates adenylyl cyclase (1) and activates a variety of G-beta-gamma-dependent pathways including the MAPK and the PI3K/Akt cascades (2,3). Trafficking of these receptors to and from the plasma membrane and their desensitization play a significant role in morphine tolerance (4,5). As with other GPCRs, these processes are modulated by phosphorylation at diverse sites within intracellular domains (6). Among other sites, agonist-specific phosphorylation of serine 375 in mouse (serine 377 in human) MOR is essential for its internalization (7).
- Law, P. Y. et al. (2000) Annu. Rev. Pharmacol. Toxicol. 40, 389-430.
- Polakiewicz, R. D. et al. (1998) J. Biol. Chem. 273, 12402-12406.
- Polakiewicz, R. D. et al. (1998) J. Biol. Chem. 273, 23534-23541.
- Finn, A.K. and Whistler, J.L. (2001) Neuron 32, 829-839.
- Kieffer, B.L. and Evans, C.J. (2002) Cell 108, 587-590.
- Yu, Y. et al. (1997) J. Biol. Chem. 272, 28869-28874.
- El Kouhen, R. et al. (2001) J. Biol. Chem. 276, 12774-12780.
Application References
- Schulz, S. et al. (2004) Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J. 23, 3282-3289. This article references the use of Phospho-mu-Opioid Receptor (Ser375) Antibody in the following applications: IC-IF Western Blotting
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 3641 Phospho-delta-Opioid Receptor (Ser363) Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.